Amoy Diagnostics Co., Ltd. (SHE:300685)
China · Delayed Price · Currency is CNY 22.44
-0.08 (-0.36%)
Mar 19, 2026, 11:55 AM CST
Amoy Diagnostics Revenue
In the year 2025, Amoy Diagnostics had annual revenue of 1.20B CNY with 8.00% growth. Amoy Diagnostics had revenue of 332.04M in the quarter ending December 31, 2025, with 27.23% growth.
Revenue
1.20B
Revenue Growth
+8.00%
P/S Ratio
7.27
Revenue / Employee
1.05M
Employees
1,144
Market Cap
8.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.20B | 88.72M | 8.00% |
| Dec 31, 2024 | 1.11B | 65.44M | 6.27% |
| Dec 31, 2023 | 1.04B | 201.33M | 23.91% |
| Jan 1, 2023 | 842.18M | -74.85M | -8.16% |
| Jan 1, 2022 | 917.03M | 188.64M | 25.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dian Diagnostics Group | 10.50B |
| Shanghai Runda Medical Technology | 7.40B |
| Guangzhou Kingmed Diagnostics Group | 6.11B |
| BGI Genomics | 3.71B |
| Maccura Biotechnology Co.Ltd | 2.21B |
| Shanghai Labway Clinical Laboratory | 1.52B |
| Beijing Strong Biotechnologies,Inc. | 1.43B |
| Thalys Medical Technology Group | 1.25B |